Posted in | News | Semiconductor | Business

TELEFUNKEN Semiconductors Expands Manufacturing Capacity at Roseville Facility

TELEFUNKEN SEMICONDUCTORS INTERNATIONAL (TSI) Announces Expansion of Manufacturing Capacity at its Roseville Foundry Facility.

TELEFUNKEN Semiconductors is pleased to announce the expansion of its manufacturing capacity at the Roseville, California facility. The first phase expansion plan provides for a 100% increase in wafer processing capability (to 220,000+ 8 inch wafers, or 5,500,000 mask layers per year). This expansion will make TELEFUNKEN’s Roseville facility one of the largest U.S.-based semiconductor foundry services companies in the United States.

“TELEFUNKEN Semiconductors is excited to announce the expansion of our manufacturing facility here in the U.S.,” said Roger Lee, President & CEO of TELEFUNKEN Semiconductors. “The increased capacity is the result our recent acquisition of the state-of-the-art semiconductor equipment from factories in Japan. The added tools will help us to satisfy the strong demand we are forecasting from our customers. This will move TELEFUNKEN Semiconductors into one of the top spots for specialty foundries in the Western world.” Mr. Lee further added, “Growing our capacity with advanced silicon processing tools and offering a comprehensive suite of strategic foundry services at a competitive cost is an important part of our overall corporate mission. This expansion is a testimony of our strong commitment to, and profound belief in, the high-tech manufacturing and R&D which are so critical to our overall economic eco-system. Our goal is to be a customer’s first choice for high-performance, competitive, specialized and trusted semiconductor foundry solutions.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.